Intodna

intoDNA is a global precision medicine company that provides biopharma and clinicians with decision-grade insights into DNA damage and repair biology to reduce risk, accelerate timelines, and enable truly precise patient care. Our patented STRIDE® platform provides single cell resolution, combined with advanced AI-driven data analysis, and delivers unique, objective, high-sensitivity results validated across therapeutic areas. We know existing modalities can fall short and envision a future where the right therapies, reach the right patients, at the right time.